A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
pH responsive Fe3O4@GT/PVA nanocomposite for drug release of hydroxychloroquine sulfate (HCQ)
[post]
2022
unpublished
Recent studies have shown the potential of hydroxychloroquine (HCQ) as a pharmaceutical agent to the treatment of a variety of cancers such as lung, melanoma, breast, pancreatic, and colon cancers. HCQ has been proposed to cure viral diseases such as Covid-19 disease. In this study, Fe3O4@PVA/GT nanocomposite has been synthesized for controlling HCQ release at pH 7.4 and 3.4 in different temperature (37 0C and 40 0C). Taguchi method (L9) with 3 levels and 3 factors was used to optimize the
doi:10.21203/rs.3.rs-1799339/v1
fatcat:pzcjt2gtynacposc36pugu6cjy